EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Lumos Diagnostics Holdings's Enterprise Value is $13.23 Mil.
Lumos Diagnostics Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.64 Mil. Therefore, Lumos Diagnostics Holdings's EV-to-FCF for today is -20.83.
The historical rank and industry rank for Lumos Diagnostics Holdings's EV-to-FCF or its related term are showing as below:
LDXHF'
s EV-to-FCF Range Over the Past 10 Years
Min: -14.65 Med: -0.2 Max: 20
Current: -14.65
During the past 3 years, the highest EV-to-FCF of Lumos Diagnostics Holdings was 20.00. The lowest was -14.65. And the median was -0.20.
LDXHF's EV-to-FCF is ranked worse than 100% of 382
companies
in the Medical Devices & Instruments industry
Industry Median: 27.355
vs LDXHF: -14.65
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Lumos Diagnostics Holdings's EV-to-FCF
For the Medical Devices subindustry, Lumos Diagnostics Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lumos Diagnostics Holdings's EV-to-FCF Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lumos Diagnostics Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Lumos Diagnostics Holdings's EV-to-FCF falls into.
Lumos Diagnostics Holdings's current Enterprise Value is $13.23 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lumos Diagnostics Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.64 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Lumos Diagnostics Holdings's PE Ratio (TTM) for today is calculated as:
Lumos Diagnostics Holdings's share price for today is $0.015.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lumos Diagnostics Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.009.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Lumos Diagnostics Holdings EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Lumos Diagnostics Holdings's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture, and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. The group is dedicated to providing contract research and development services, focusing on the innovation, development, manufacturing, and commercialization of point-of-care diagnostic solutions for both clinical and consumer applications. It generates maximum revenue from commercial services and solutions relating to POC diagnostic tests. The group has one operating segment, which is the provision of point-of-care diagnostics goods and services, and it operates across two geographical regions, the United States and Australia. and the majority of revenue is generated from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LDXHF has been successfully added to your